Subscriber login:
Remember me
IPD's Portfolio & Formulation Insights subscription empowers generic drug selection teams to make insight-driven decisions in a dynamic, ever-changing landscape. Transforming complex, siloed insights into cohesive intelligence to drive timely, confident, and harmonized portfolio decisions across the organization with:
Sales Forecast and Epidemiology
Visualize brand revenue potential through comprehensive forecasts and patient-based epidemiology models.
Patent Landscape
Access key loss-of-exclusivity patent information for life-cycle risk assessment and early-stage planning.
Generic Opportunity Assessment
Benchmark generic launch analog performance, identify first filers and likely competitors, and track market surveillance indicators.
API Cost Information
Understand actual or estimated API costs to guide development, early COGS modeling, and estimate potential margins.
Financial Model and Insights
Estimate commercial viability, compare multiple launch scenarios, translate complex inputs into actional metrics, and download customizable models to refine assumptions and align with internal development, cost, and market planning frameworks.
Commercial and Competitive Assessments
Formulation and Regulatory Feasibility
Manufacturing Cost Intelligence
Dynamic, Downloadable Financial Models
Formulation Strategy
Identify viable formulation strategies, evaluate design-around opportunities, and clarify technical feasibility for development.
%20Insights%20Icon.jpg){kind=small}
Bioequivalence (BE) Insights
See predicted FDA BE guidance for a reference product, including study design, Q1/Q2 sameness, and other requirements.
Polymorph Insights​
Visualize claimed versus disclosed polymorphs across U.S., EU, and PCT patent filings to inform patent strategy and API selection.
Chemical Synthesis Insights
Evaluate routes of synthesis and intermediates identified from patents to estimate API feasibility, yield, and scalability.